<< Back to Home Page
Providing a comprehensive range of anesthesia and critical care products including inhalation anesthetics, cardiovascular beta-blocking agents, a broad range of generic injectables, level of sedation monitoring, airway management and regional anesthesia.
Providing a comprehensive range of therapeutic proteins derived from plasma and through innovative recombinant technology. These high-quality, leading therapies are used to enhance the lives of patients requiring support for hemostasis, immune deficiencies, Alpha1-PI deficiency, and hemophilia and other blood-related disorders.
This product catalogue contains a comprehensive listing of all Medication Delivery products available from Baxter Canada.
To promote a safer healthcare environment, we have expanded our integrated portfolio to include products and information technologies specifically designed to reduce medication errors and improve patient safety, drive down cost and promote labor efficiencies. Individually, each of our products is designed on a platform of safety and efficiency. When utilized together as a system, even greater benefits can be realized.
The Baxter oncology portfolio consists of innovative and economical therapeutic solutions for the treatment of cancer.
Basic information on our products as approved by Health Canada.
Kidney Therapies: treatments for patients with renal failure.
Use our search tool to find MSDS sheets for Baxter products.
Consolidated Terms and Conditions Document (pdf 10k)
Print this page
